Testing the effect of rare variants on phenotypic variation is difficult due to the need for 2 extremely large cohorts to identify associated variants given expected effect sizes. An alternative 3 approach is to investigate the effect of rare genetic variants on low-level genomic traits, such as 4 gene expression or DNA methylation (DNAm), as effect sizes are expected to be larger for low-level 5 compared to higher-order complex traits. Here, we investigate DNAm in healthy ageing populations -6 the Lothian Birth cohorts of 1921 and 1936 and identify both transient and stable outlying DNAm 7 levels across the genome. We find an enrichment of rare genetic variants within 1kb of DNAm sites 8 in individuals with stable outlying DNAm, implying genetic control of this extreme variation. Using a 9 family-based cohort, the Brisbane Systems Genetics Study, we observed increased sharing of DNAm 10 outliers among more closely related individuals, consistent with these outliers being driven by rare 11 genetic variation. We demonstrated that outlying DNAm levels have a functional consequence on 12 gene expression levels, with extreme levels of DNAm being associated with gene expression levels 13 towards the tails of the population distribution. Overall, this study demonstrates the role of rare 14 variants in the phenotypic variation of low-level genomic traits, and the effect of extreme levels of 15 DNAm on gene expression. 16 ~282,000 pairs of CpG-sites at a median distance of ~110kb [22]. Overlap between mQTL and gene 33 expression QTL (eQTL) has also been observed [14, 21], with genetic variants found to affect DNAm 34 and gene expression levels pleiotropically [22, 24]. These observations point towards a possible 35 mechanism through which genetic variants can alter gene expression levels via underlying 36 differences in DNAm levels in a region. 37
Introduction
DNA methylation (DNAm) is involved in the regulation of gene expression [1] [2] [3] , as well as 18 genomic imprinting [4] , X-chromosome inactivation [5] , and the maintenance of genomic stability 19 during mitosis and cell differentiation [6] [7] [8] . Variation in DNAm has been associated with many 20 diseases, in particular cancers [9, 10] , but also common disease [11] such as Parkinson's disease [12] , 21 and rheumatoid arthritis [13] . Both genetic [14, 15] and environmental [16] [17] [18] factors are highly 22 influential to the variation in DNAm levels across the genome. Studying the genetic architecture of 23
DNAm can help us to understand the genetic control of DNAm and potential mechanisms through 24 which genetic variants can affect complex traits via effects on DNAm. 25 Variation in DNAm levels is known to be under partial genetic control; a family based study 26 estimated the average heritability of DNAm levels to be ℎ 2 ̅̅̅~1 9% [15] , whilst another study 27 estimated the average SNP-based heritability to be ℎ 2 ̅̅̅̅̅̅~2 1% [19] . DNA methylation quantitative 28 trait loci (mQTL) analyses have discovered many associations between common genetic variants and 29
DNAm levels across the genome [14, [19] [20] [21] [22] . Regional control of DNAm has been observed in regions 30 of up to 3kb, through shared mQTL and correlations between DNAm levels across the region [14, 31 23] , while a Bayesian co-localisation study found evidence for a shared genetic effect between 32 effect sizes. Various statistical methods have been developed to detect rare variant associations, gaining power by aggregating the effects of multiple rare variants, or looking for unusual variances in 43 the effect sizes of rare variants in a region [31] [32] [33] [34] [35] [36] [37] . Using one of these rare variant association tests, 44 there has been evidence of effects from rare variants on DNAm levels, even when there is no 45 common variant association at the relevant CpG-site [38] . Rare variants have also been found to be 46 enriched near the transcription start site (TSS) of genes in individuals with outlying levels of gene 47 expression, particularly in those individuals with outlying levels of gene expression across multiple 48 tissue types [27] . Other studies have found that the number of rare alleles within a region of the TSS 49 of genes is on average higher in those individuals with lower, or higher levels of methylation than 50 the population average, in both humans [39] and maize [40] . These rare variants are likely to be in 51 promoter regions; hence, it is possible that they affect the DNAm levels in CpG-islands, which can 52 have an effect on the gene expression levels [1, 41] . 53
In this study, we investigate the effect of rare genetic variation on DNAm levels across the 54 genome, and how DNAm levels may affect gene expression levels at nearby genes. We hypothesise 55 that, similar to the association found between rare variants and outlying gene expression levels [27, 56 39, 40] , there are associations between rare variants and outlying levels of DNAm. Outliers in DNAm 57 have been associated with common diseases such as motor neurone disease [42] and type I diabetes 58 [43] , understanding the underlying mechanisms may help in determining the genetic etiology of 59 these associations. In addition, CpG-sites are known to be highly mutable, with the mutation rate at 60
CpG-sites estimated to be one order of magnitude higher than anywhere else in the genome, which 61 results in an enrichment of mutations at CpG-sites in the genome [44, 45] . Knowing how mutations 62 at CpG-sites will affect DNAm and gene expression levels in the genome may also be important for 63 understanding the genetic etiology of complex trait diseases and cancers.
Results

66
An overview of the methods used in this study, with the different data available to us is given in 67 1921 and 1936 [46] , we tested for global effects of both rare and common genetic variants on DNAm 72 levels across the genome. At each of the ~460,000 DNAm probes, individuals were ranked from 73 lowest DNAm level to the highest, and the number of minor alleles within 1kb of the CpG-site were 74 counted for each individual within a given minor allele frequency range. We then averaged the 75 minor allele counts for each rank at each DNAm probe. If there is no genetic effect on DNA 76 methylation for single nucleotide polymorphisms (SNPs) with a given allele frequency range, we 77 would expect no relationship between the average minor allele count across ranks. We observe an 78 inflation in allele counts at the lowest and highest ranks, for all MAF ranges ( Figure 2 ), suggesting 79 genetic effects from variants across all MAF ranges. 80
For the common variants (MAF > 0.1), we show that these effects are largely captured by mQTL 81 analyses ( Figure 3 ) by separating the ~50,000 probes with a significant mQTL detected in previous 82 studies [20] . The inflation at the ends of the distribution remains for the DNAm probes with a known 83 mQTL, while the majority of the inflation is removed for the remaining probes. This indicates that 84 the majority of the relationship between methylation rank and SNPs for common variants is 85 captured by known mQTL. 86
We also observe that the association between minor allele counts and methylation rank is not 87 symmetrical, with the lowest ranks having a larger inflation than the highest ranks in the MAF bins. genome. However, after separating the probes which contain a SNP at the CpG-site (CpG-SNP) from 90 the rest of the probes, we see that the inflations are symmetrical for probes which do not contain a 91
CpG-SNP ( Figure 4 ). This suggests that the allele disrupting the CpG site is, on average, the minor 92 allele, which may be attributed to a combination of bias in selection of CpG sites included on the 93 array (sites which are generally CpGs were chosen), and a known mutational bias in the genome 94 from (methylated) cytosine to thymine through the process of deamination [44] . We have shown 95 that the effect of SNPs outside of the CpG-sites are approximately equally likely to increase or 96 decrease DNAm levels ( Figure 4 ). 97
While inflation in the minor allele count is observed for individuals with either lowly or highly 98
ranked methylation values for all MAF classes, for the rare variants (MAF<0.001 and 99 0.001<MAF<0.01) we see that the inflation is largely restricted to the extremes of the distribution. 100 This is consistent with rare variants driving more extreme levels of DNAm. 101 Enrichment in rare alleles in individuals with outlying DNA methylation [1.190, 1.222], [1.174, 1.193], and [1.157, 1.164] for variants with MAF<0.001, 0.001<MAF<0.01, and 115 0.01<MAF<0.1 respectively) within 1kb of the CpG-sites in individuals with outlying DNAm levels 116 compared to individuals with non-outlying DNAm levels at all time-points ( Figure 5 ). The enrichment 117 in outliers remained statistically significant after removing the probes with a CpG-SNP (These probes 118 may bias the enrichment as they will disrupt the methylation at the site which will likely result in 119 outliers [48] ). The enrichment of rare alleles in outliers compared to non-outliers stable across three 120 to four time-points was larger ([1.356, 1.517 probes with a CpG-SNP for variants with MAF<0.001, 0.001<MAF<0.01, and 0.01<MAF<0.1 126 respectively. Figure 6 ). 127
Outliers in gene-expression and DNA methylation are shared between relatives across the genome. However, there was very little overlap between gene expression outliers and DNAm outliers, with 6.1% of individuals with a gene expression outlier also having a DNAm outlier at 140 the nearest annotated gene. 141
Outlying levels of DNA methylation are associated with a change in gene-expression 142 Although the overlap of outlying DNAm and gene expression was not substantial, we tested 143 whether the outlying DNAm levels correlates with any change in gene expression levels. For 144 individuals with outlying levels of DNAm at a CpG-site, if the DNAm levels have no effect on gene 145 expression levels, we would expect those individuals to be uniformly distributed across the gene 146 expression distributions. Firstly, we paired DNAm probes to gene expression probes using significant 147 common variant co-localisation established using a summary data-based Mendelian randomisation 148 (SMR) study [24] . The rank of gene expression levels for individuals with outlying methylation levels 149 at SMR-linked probes showed significant deviance from the uniform distribution Smirnov one sample test D=0.03, p<10 -323 , Figure 8 ), indicating an association between outlying 151 levels of DNAm levels on gene expression levels. 152
Secondly, we relaxed the criteria for linked DNAm and gene expression probes, using a distance-153 based pairing, taking all probe pairs within 10kb of each other. This introduced more noise into the 154 analysis as not all DNAm and gene expression probes will be linked in any way. However, we still 155 observed a significant deviation from the uniform distribution (Kolmogorov-Smirnov one sample test 156 D=0.006, p<10 -323 , Figure 9 ). These results correspond to a correlation between outlying levels of 157 DNAm and a change in gene expression levels at the relevant genes. 158
Discussion
159
This study examined the links between DNAm levels, rare genetic variants, and gene expression 160 levels across the genome. We combined multiple lines of evidence to demonstrate the role of rare variants in outlying DNAm levels. Outlying levels of DNAm are further demonstrated to be associated 162 with gene expression levels at nearby genes. 163
We examined the patterns of effects from common and rare genetic variants, within 1kb of the 164 CpG-site, on DNAm levels across the genome. We found that rare alleles were associated with 165 extreme levels of DNAm. In addition, we observed a significant enrichment of rare alleles within 1kb 166 of CpG-sites in individuals with outlying levels of DNAm compared to individuals with normal DNAm 167 levels at that CpG-site. Our results suggest that, in addition to common variants, rare variants also 168 play a role in the control of DNAm levels across the genome. 169
DNAm levels at many CpG-sites are known to be correlated with age [23, 50] , and changes in 170 environment are also known to have an effect across time [16] [17] [18] . In our analysis, we found that 171 outliers in DNAm levels which are present at only one time-point had almost no enrichment for rare 172 alleles within 1kb of the CpG-site compared to non-outliers, but those probes outlying across 173 multiple time-points within an individual had significant enrichment. Previous studies have found correlations between DNAm and gene expression, and an overlap in 189 the association of common genetic variants between them [14, 21, 41, [52] [53] [54] [55] . In this study, we 190
show that outliers in DNAm levels are associated with a change in gene expression levels at nearby 191 genes. Summary-data based Mendelian randomisation [56] analyses have provided us with evidence 192 of pleiotropic effects of common variants on DNAm and gene expression levels across the genome 193 [22, 24] . In addition, the proportion of phenotypic variance explained by the lead variant at a mQTL 194 was, on average, larger than the phenotypic variance explained by the same variant at a co-localised 195 eQTL and at a co-localised higher-order complex trait QTL, such as height [24] . This attenuation in 196 effect size of the variant at each step suggests a mechanism of effect from genetic variant to DNAm, 197 to gene expression, to higher-order complex trait. In this study, we observed that large differences 198 in DNAm often corresponded to smaller differences in gene expression, which would fit into this 199 hypothesised directional mechanism of effect. In addition, the difference in slope in Figure 7 also 200 suggests a larger effect from genetic variation on DNAm levels, than gene expression levels. This 201 mechanism may be important to consider, as DNAm has been shown to be associated with many 202 common diseases [11] , and as methylation outliers are relatively easy to detect, it could provide a 203 useful tool for future research. 204
A limitation of our study was that of the two data sets available to us, one (LBC) had WGS and 205
DNAm array data, whereas the other (BSGS) had SNP array, DNAm array and gene expression array 206 data. Ideally the study would be conducted on a cohort with all data types. With the increasing 207 availability of whole genome sequence data, as well as RNA-seq and DNAm array/bisulfite sequence 208 data, a more comprehensive study of the effects of rare variants on both DNAm and gene expression 209 would provide a better understanding of the mechanisms underlying genetic effects on complex gene expression [54, 57] . We hypothesise that other epigenetic modifications may also show similar 213 patterns of effects to what we found in DNAm, and including these into future analyses could 214 potentially provide a more complete picture of the shared genetic control between DNAm, other 215 epigenetic modifications, and gene expression. 216
In summary, this study provides a novel insight into the effect of rare variants on DNAm levels 217 across the genome, and shows that extreme differences in DNAm are associated with gene 218 expression levels at nearby genes, which may be driven by rare genetic variation. 219 Of the 1342 individuals with DNAm measured at one point, 642 had at least three timepoint 230 measurements. While DNAm levels across the genome are known to change with age [23, 50] , this is 231 not a confounding factor in our analysis as the age ranges within each wave of measurement are 232 very narrow (mean standard deviation of age for each cohort in each wave was 0.6 years). 233
Whole genome sequencing was performed on the HiSeq X with an average coverage of 36x 
Brisbane Systems Genetics Study 239
The Brisbane Systems Genetics study (BSGS) [49] was a dataset designed to study the genetic 240 effects on gene expression, and the role of gene regulation in complex traits. DNAm levels were 241 measured, in whole blood using the Illumina Infinium HumanMethylation450 BeadChip array, on pairs, and parents. The QC of the DNAm data was performed using the same pipeline as with the LBC 244 data. gene expression levels were measured in whole blood on 846 individuals using the Illumina 245
HumanHT-12 v4.0 BeadChip array. The QC of the gene expression data are detailed in Lloyd-Jones et 246 al. 2017 [63] . Briefly, the gene expression levels were normalised using variance stabilization [64], 247 quantile normalised using the limma software [65], followed by PEER factor adjustment [66], with 50 248 factors, correcting for covariates such as age, sex, cell counts, and batch effects. Both DNAm and 249 gene expression levels were measured on a total of 595 individuals. 250
An overview of the methods used to investigate the effects of genetic variants on DNAm levels 251 and gene expression levels using the LBC and BSGS datasets are shown in Figure 1 . 252 counted the number of minor alleles within 1kb of the CpG-site for each individual. We averaged this 256 value at each rank across all autosomal probes to get the mean number of minor alleles within 1kb 257 of a CpG-site. We did this for 4 MAF ranges, MAF>0.1, 0.1>MAF>0.01, 0.01>MAF>0.001, and 258 0.001>MAF, which allowed us to separate the effects of common and rare variants. The rarest MAF 259 bin (MAF<0.001) corresponded to variants with one or two observed minor alleles in our dataset. 260
Detecting genome-wide effects on DNAm
This analysis was performed using the 1 st wave of measurements in the LBC dataset to maximise 261 sample size. 262
Detecting outliers 263 We defined DNAm outliers as a CpG-site in an individual with DNAm levels outside 3 264 interquartile ranges (IQRs) from the 1 st quartile (Q1) or the 3 rd quartile (Q3) of the DNAm levels at 265 that CpG-site. The standard 1.5 IQRs from Q1 or Q3 compares to 3 standard deviation from the 266 mean in a perfectly normal distribution. Our definition is slightly more stringent than this, as the distribution of DNAm levels can be highly skewed. For detecting outliers in the gene expression data, which had more symmetric distributions, the standard 1.5 IQR from Q1 and Q3 definition was used. 269 , where n1 is the number of outliers for individual one, n2 is the number of outliers for 280 individual two, and n12 is the number of outliers shared between the individuals. The relatedness 281 coefficients were obtained from pedigree data. 282
Enrichment of rare alleles around CpG-sites
Testing for association between outlying levels of DNAm and gene expression 283
To test for an association between outlying levels of DNAm and gene expression, the percentile 284 in the gene expression levels distribution at a gene expression probe was calculated for each 285 individual with outlying DNAm levels at the paired DNAm probe. We used two methods to pair 286 DNAm probes to gene expression probes. Firstly, we linked DNAm probes through a shared common 287 variant co-localisation with the gene expression probe detected using the Summary-data based 288 probes within 10kb of the CpG-sites. This represents a trade-off between number of pairs included in 290 the analysis and including pairs of gene expression and DNAm probes that have no biological 291 connection beyond proximity. Under the null hypothesis of no association between outlying DNAm 292 and gene expression levels, the rank of gene expression levels for individuals with outlying DNAm 293 levels should be uniformly distributed. We tested for deviation from the uniform distribution using 294
the Kolmogorov-Smirnov one sample test [67] , which tests the degree of agreement between the 295 sampled values and a theoretical distribution, in our case the uniform distribution. 296 p. 6-21. 300 
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Fan, S. and X. Zhang, CpG island methylation pattern in different human tissues and 301 its correlation with gene expression. Biochem Biophys Res Commun, 2009. 383(4) to examine the effect of DNA methylation levels on gene expression levels. In subfigure a, the number of minor alleles 456 within 1kb is plotted against methylation rank (The individual with the n th lowest DNAm levels will have a methylation rank 457 of n at that CpG-site); in the case of no effect of genetic variants on DNAm levels, a uniform distribution is expected, any 458 deviation from the uniform distribution is evidence for a genetic effect on DNAm levels. Subfigure b shows the enrichment 459 of minor alleles within 1kb in outliers compared to non-outliers; in the case of no effect of genetic variants on DNAm 460 outliers, the enrichment will be 1, any significant deviation from 1 is evidence of an effect of genetic variants on outliers of 
